Search results
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 1 day agoMeanwhile, the midpoint of its sales guidance in 2024 is $60 billion. That's an estimated sales increase of 43% in four years, which is pretty impressive...
2 No-Brainer Dividend Stocks to Buy in May
Motley Fool via Yahoo Finance· 7 days agoThe company's stock felt the pressure from a downturn in COVID-19 product sales last year, and the investment community expressed dissatisfaction with &...
Pfizer's next move: Can it break above $30? | Invezz
Invezz· 3 days agoPfizer Inc. (NYSE:PFE) faced a challenging 2023 in the stock market, with its shares plummeting from over $50 to a low of $25. On May 1, 2024, Pfizer...
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Benzinga via Yahoo Finance· 3 days agoPfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 2 days agoThe drug maker experienced a massive surge in sales and earnings during the COVID-19 pandemic's...
The AstraZeneca vaccine – should you be worried?
The Telegraph via Yahoo News· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company...
7 Cheap Value Stocks to Buy Now: May 2024
InvestorPlace· 1 day agoThe major stock market indexes are near record highs. The good news, however, is that investors can still put money to work in today’s market without...
'Seems Low:' Elon Musk Questions Pfizer's $0 Tax Bill, But Did Tesla Pony Up To Uncle Sam? - Pfizer...
Benzinga· 3 days agoHappened: The issue began on X, the platform Musk owns, where Ashley St. Clair, a contributor to...
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Motley Fool via Yahoo Finance· 3 days agoTotal sales, for instance, fell by 19% year over year. When excluding COVID-19 revenue, however,...
Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial
Reuters· 3 days ago, opens new tab said on Monday its pill-based treatment for COVID-19 did not meet the primary...